SSII

+ Watchlist + Portfolio

SS Innovations International Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $3.60
52-Week Range: $3.11 – $10.00
Market Cap: $723.39M
P/E (TTM): —
EPS (TTM): -0.06
Dividend Yield: —

Advanced Metrics

Price/Book: 13.27
PEG Ratio: —
Return on Equity: -26.06%
Return on Assets: -6.34%
Gross Margin: 47.65%
Operating Margin: -16.29%
Profit Margin: -23.72%
Current Ratio: 2.24
Debt/Equity: 0.33
Total Debt: $17.87M
Free Cash Flow: $-3.90M
Revenue Growth: 39.40%
Earnings Growth: —
Enterprise Value: $727.62M

SSII Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$1.44M	$5.88M	$20.65M	$42.48M
Cost of Revenue	$1.38M	$5.15M	$12.20M	$22.94M
Gross Profit	$60.58K	$725.53K	$8.45M	$19.54M
Research & Development	$987.44K	$1.06M	$2.49M	$3.69M
Selling, General & Admin	$1.94M	$19.79M	$24.50M	$22.98M
Operating Expenses	$3.02M	$21.00M	$27.43M	$27.74M
Operating Income	-$2.96M	-$20.27M	-$18.98M	-$8.19M
EBITDA	-$2.85M	-$19.83M	-$17.74M	-$5.98M
Pretax Income	-$3.21M	-$20.88M	-$19.15M	-$8.16M
Income Tax	$0.00	$0.00	$0.00	$3.97M
Net Income	-$3.21M	-$20.88M	-$19.15M	-$12.13M
Diluted EPS	-0.03	-0.14	-0.11	-0.06
Diluted Shares	128.16M	152.07M	181.20M	198.70M

SSII Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$217.18K	$2.02M	$466.50K	$3.21M
Receivables	$2.49M	$3.81M	$7.16M	$18.23M
Inventory	$904.10K	$7.02M	$10.21M	$17.06M
Current Assets	$4.10M	$21.43M	$27.42M	$48.80M
Total Assets	$6.98M	$31.52M	$42.39M	$74.23M
Current Liabilities	$7.77M	$8.47M	$21.33M	$26.24M
Long-Term Debt	$469.02K	—	—	—
Total Debt	$8.27M	$9.28M	$18.20M	$14.36M
Total Liabilities	$9.66M	$11.80M	$28.93M	$36.01M
Retained Earnings	-$3.63M	-$24.51M	-$43.66M	-$55.79M
Shareholders' Equity	-$2.68M	$19.72M	$13.46M	$38.22M
Working Capital	-$3.67M	$12.95M	$6.09M	$22.56M
Net Debt	$6.50M	$4.51M	$14.98M	$8.24M

SSII Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$5.99M	-$15.36M	-$9.50M	-$18.54M
Capital Expenditure	-$220.32K	-$453.33K	-$661.48K	-$3.66M
Free Cash Flow	-$5.99M	-$15.81M	-$10.16M	-$22.20M
Depreciation & Amortisation	$96.58K	$152.74K	$436.00K	$1.08M
Stock-Based Compensation	$0.00	$9.72M	$14.34M	$8.13M
Investing Cash Flow	$240.82K	-$453.33K	-$661.48K	-$3.66M
Financing Cash Flow	$5.90M	$22.80M	$9.43M	$26.17M
Net Change in Cash	$142.50K	$6.98M	-$738.53K	$3.96M

SSII Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$5.12M	$10.00M	$12.83M	$14.53M	$11.10M
Cost of Revenue	$4.03M	$4.09M	$6.66M	$8.16M	$5.77M
Gross Profit	$1.09M	$5.92M	$6.16M	$6.38M	$5.33M
Research & Development	$1.01M	$498.60K	$786.32K	$1.39M	$995.44K
Selling, General & Admin	$5.79M	$5.06M	$6.92M	$5.41M	$7.65M
Operating Expenses	$7.01M	$5.82M	$8.00M	$7.11M	$8.97M
Operating Income	-$5.92M	$97.01K	-$1.84M	-$735.00K	-$3.64M
EBITDA	-$5.09M	$574.20K	-$1.40M	-$60.94K	-$2.82M
Pretax Income	-$5.68M	$97.04K	-$1.87M	-$705.73K	-$3.43M
Income Tax	$0.00	$353.73K	$1.85M	$1.77M	$151.35K
Net Income	-$5.68M	-$256.69K	-$3.72M	-$2.47M	-$3.58M
Diluted EPS	-0.03	0.00	-0.02	-0.01	-0.02
Diluted Shares	188.60M	202.84M	202.86M	194.17M	205.31M

SSII Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$15.87M	$11.38M	$5.68M	$3.21M	$15.98M
Receivables	$8.04M	$5.97M	$6.92M	$18.23M	$20.26M
Inventory	$14.30M	$18.26M	$20.04M	$17.06M	$17.07M
Current Assets	$47.62M	$50.79M	$48.42M	$48.80M	$66.26M
Total Assets	$63.46M	$69.98M	$69.58M	$74.23M	$90.55M
Current Liabilities	$15.00M	$19.61M	$21.19M	$26.24M	$26.05M
Total Debt	$10.45M	$9.79M	$12.68M	$14.36M	$13.82M
Total Liabilities	$22.90M	$27.95M	$29.93M	$36.01M	$36.02M
Retained Earnings	-$49.34M	-$49.60M	-$53.32M	-$55.79M	-$59.37M
Shareholders' Equity	$40.55M	$42.02M	$39.65M	$38.22M	$54.52M
Working Capital	$32.62M	$31.18M	$27.24M	$22.56M	$40.22M
Net Debt	—	—	$4.39M	$8.24M	—

SSII Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$6.10M	-$3.45M	-$7.47M	-$1.52M	-$2.31M
Capital Expenditure	-$872.80K	-$316.65K	-$755.08K	-$1.71M	-$54.19K
Free Cash Flow	-$6.98M	-$3.77M	-$8.22M	-$3.23M	-$2.37M
Depreciation & Amortisation	$208.88K	$260.36K	$297.17K	$309.49K	$323.75K
Stock-Based Compensation	$2.38M	$1.63M	$2.10M	$2.02M	$3.14M
Investing Cash Flow	-$872.80K	-$316.65K	-$755.08K	-$1.71M	-$54.19K
Financing Cash Flow	$22.41M	-$702.10K	$3.09M	$1.37M	$18.16M
Net Change in Cash	$15.43M	-$4.47M	-$5.13M	-$1.86M	$15.79M

Market Snapshot

About

SS Innovations International develops and commercializes robotic surgical systems for minimally invasive procedures. The company focuses on making advanced surgical robotics more accessible and affordable, particularly in emerging markets. Headquartered in India with operations in multiple countries.